Filing Details

Accession Number:
0001104659-18-019364
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-21 17:16:20
Reporting Period:
2018-03-19
Accepted Time:
2018-03-21 17:16:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527710 Patrick James Tursi C/o Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Disposition 2018-03-19 5,950 $1.70 251,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.